Spara
Phosphoinositide 3-kinase in Health and Disease
From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress.
- Undertitel
- Volume 1
- Redaktör
- Christian Rommel, Bart Vanhaesebroeck, Peter K. Vogt
- Upplaga
- 2011 ed.
- ISBN
- 9783642265228
- Språk
- Engelska
- Vikt
- 310 gram
- Utgivningsdatum
- 2012-11-07
- Sidor
- 310
